Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US6960577 | ELI LILLY AND CO | Combination therapy for treatment of refractory depression |
Nov, 2017
(6 years ago) |
Drug Exclusivity | Drug Exclusivity Expiration |
---|---|
New Indication(I-589) | Mar 19, 2012 |
New Patient Population(NPP) | Jul 26, 2016 |
Market Authorisation Date: 23 December, 1992
Treatment: Prozac and olanzapine in combination for the acute treatment of treatment resistant depression in adults
Dosage: CAPSULE;ORAL
Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
USRE39030 | LILLY | Fluoxetine enteric pellets and methods for their preparation and use |
May, 2017
(6 years ago) | |
US5910319 | LILLY | Fluoxetine enteric pellets and methods for their preparation and use |
May, 2017
(6 years ago) | |
US5985322 | LILLY | Method for the treatment of CNS disorders |
May, 2017
(6 years ago) | |
US5985322 (Pediatric) | LILLY | Method for the treatment of CNS disorders |
Nov, 2017
(6 years ago) | |
US5910319 (Pediatric) | LILLY | Fluoxetine enteric pellets and methods for their preparation and use |
Nov, 2017
(6 years ago) |
Market Authorisation Date: 26 February, 2001
Treatment: Method of treating people suffering from depression without an increase in nausea; Method of treating people suffering from depression
Dosage: CAPSULE, DELAYED REL PELLETS;ORAL